Logo image
Interferon-Gamma responses to candida recover slowly or remain low in immunodeficient HIV patients responding to ART
Journal article   Peer reviewed

Interferon-Gamma responses to candida recover slowly or remain low in immunodeficient HIV patients responding to ART

K. Burgess, P. Price, I.R. James, S.F. Stone, N.M. Keane, A.Y.F. Lim, J.R. Warmington and M.A. French
Journal of Clinical Immunology, Vol.26(2), pp.160-167
2006
url
Link to Published Version *Subscription may be requiredView

Abstract

Extended assessments of memory T-cell responses in HIV patients who have a satisfactory virological response to combination antiretroviral therapy (CART) have been limited by availability of longitudinal samples and of antigens to which most individuals (including HIV-negative controls) have been exposed. Studies of cytomegalovirus (CMV) show that interferon-gamma (IFN-;3) responses never recover completely, but this may be antigen-specific. Here we present responses to Candida and CMV antigens analyzed using a statistical approach that derives overall trends from samples collected at variable time points. Results were considered in relation to putative markers of T-regulatory cells. Blood mononuclear cells collected from seventeen HIV-1 patients (nadir <100 CD4 T cells/mL) 0 138 years after initiation of CART were stimulated with Candida spp lysate, Candida enolase protein or CMV lysate and production of IFN-;3 was assessed by ELISpot assay. CD4 T-cell counts increased fivefold and stabilized within 24 months on CART, following control of plasma viremia. IFN-;3 responses to Candida antigens began low and increased slowly, generating positive slope up to 60 months on CART (Candida enolase p=0.008; Candida lysate p=0.03; mixed-model Wald test). Only two patients displayed a CMV or Candida-specific IFN-;3 response above the median for seronegative controls. Proportions of T cells expressing CD25 or CD57 did not correlate with IFN-;3 responses. Slow reconstitution of IFN-;3 responses to CMV and Candida in previously immunodeficient patients with restored CD4+ T-cell counts on CART suggests a broad and nonresolving defect in memory T-cell responses.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.66 HIV
1.66.46 HIV Pathogenesis
Web Of Science research areas
Immunology
ESI research areas
Immunology
Logo image